report Advocacy
IFPA's most significant advocacy achievement
Resolution on Psoriasis
26 May 2014
By IFPA
Before 2014, psoriasis was absent from the international agenda. Very few policy-makers had ever heard about the disease. The World Health Organization (WHO)’s website provided almost no info on it. Few took psoriasis seriously.
So IFPA set an ambitious target: to get the WHO Member States to adopt an official Resolution on psoriasis. This would be a powerful signal to states around the world to take action on psoriasis.
In May 2014, the 67th World Health Assembly officially adopted Resolution WHA 67.9.
This Resolution is the only international resolution focusing solely on psoriasis. It states that psoriasis:
- Is a chronic, painful, disfiguring and disabling non-communicable disease, without a cure;
- Has physical as well as psycho-social and socio-economic consequences;
- Is connected to psoriatic arthritis and increases the risk of various co-morbid diseases;
- Can lead to immense, needless suffering due to insufficient access to healthcare.
Because of this, the Resolution is a historic milestone for the global psoriasis community.
2014
The World Health Assembly unanimously approves the Resolution on Psoriasis
Download the Resolution on Psoriasis
Additional resources on psoriasis from WHO
Related content
tool Advocacy, Toolkits
Design it right: A checklist for diverse, equitable, patient-first trials
tool Advocacy, Toolkits
Glossary: Common terms in clinical research
tool Advocacy, Toolkits
Before you join a study: A practical guide for participation in clinical trials
tool Advocacy, Toolkits
Breaking The Myths: Clinical trials and psoriatic disease
Article Advocacy, News
“Health right is a human right”
Article Advocacy, News
“We want to raise awareness and break stigma around psoriasis in Paraguay”
Article Advocacy, News
Patient organizations are crucial to achieving equitable healthcare globally